Question Bank › Scarcity premium: the thing the company sells is

Scarcity premium: the thing the company sells is becoming harder to get, and management is letting the…

Scarcity premium: the thing the company sells is becoming harder to get, and management is letting the shortage do the s

Calls Tested
484
Answered YES
12
Hit Rate
2.5%
rare by design

Green Plains Inc. (GPRE) — this company's answers

NO on the Q4 2023 call 2024-02-07 F
The model's full reasoning — Q4 2023 call → NOWe need to determine if management conveys that what the company sells is becoming harder for buyers to obtain, and that management is allowing that tightening to work in its favor. We need to look for statements about product availability, demand outstripping supply, management being selective, raising prices, etc. From the transcript: Todd Becker discusses 60% protein: "We are in enough discussions right now and I've identified enough demand that would take all of our product if we can get them to buy it and that's really what it comes down to and it just takes time and so whether it's going to be starting in the middle of this year, which is kind of what we're hoping for is to start getting one of our plants sold out for the next 12 months." That suggests demand is high, but they are negotiating. They say "we have enough identified demand to take all of our product. We just got to get it to that next point." That indicates demand is there, but they are not yet selling all at 60%? They are working on commercial agreements. They also say "we are making sure we get paid for what the product is worth." That suggests they are being selective about pricing. Also, for dextrose: "we continue to have strong interest in our low-carbon intensity dextrose products. Stay tuned for some announcements on commercial agreements as we are in late-stage negotiations with several current counterparties for a significant portion of our production over the next several years." That suggests demand is strong, but not necessarily that availability is tightening. For 50% protein: "we continue to see strong demand for our ultra-high protein products." But they also say "we feel the international markets are proving to be more valuable to us for realization of better pricing, and we expect that in the future. A larger share of what we do will be in the 50 pro markets and that will be offshore." That suggests they are shifting to higher-priced markets, but not necessarily that supply is scarce. The question is about whether the company's own product is becoming harder to obtain. The transcript mentions that they have enough demand to take all of their 60% protein, but they are still negotiating. They are not yet at the point where they are turning away customers. They are still trying to get commercial agreements.

← Back to the full GPRE analysis

Show the exact prompt the model was given
Using ONLY the supplied earnings call transcript and no outside information: On this call, does management convey that WHAT THE COMPANY SELLS IS BECOMING HARDER FOR BUYERS TO OBTAIN — that availability of the company's own product, service, capacity, slots, units, or expertise is tightening relative to what buyers want — AND that management is allowing that tightening to work in the company's favor, rather than racing to eliminate it? Answer YES when management's own words convey, in whatever form fits the business, ONE coherent situation as a present-tense reality: buyers who want what the company offers are finding it less available than before — longer waits, limited availability, output spoken for ahead of time, access that must be secured rather than assumed — and management describes responding to that scarcity from a position of choice: holding or raising price, being selective about which business to take, letting customers wait rather than over-expanding, or otherwise letting the shortage improve the terms on which the company does business. The scarcity may arise from any direction — the company's own deliberate restraint, industry capacity limits, slow-to-add supply, or demand simply outrunning what exists — and the form may vary widely across industries. What matters is that management presents the tightening as real and current, and treats it as something that strengthens the company's hand rather than as a problem to be urgently fixed. Answer NO if the company is comfortably supplying everything asked of it, or is chiefly working to stimulate, win, or defend demand. NO if the shortage described is of things the company BUYS — components, materials, freight, labor — that constrain its own shipments, without buyers competing for the company's own scarce output. NO if management describes the tightness purely as a problem it is urgently fixing, with no sense that it is improving the company's pricing, selectivity, or terms. NO if the scarcity is only anticipated for the future, or is presented as a brief disruption already resolved. NO if management merely reports strong demand or a good quarter without any sense that availability is tightening relative to demand. NO if the idea appears only in an analyst's question that management does not itself affirm. Use only the supplied transcript. Answer only YES or NO.

Companies that answered YES

TickerCompanyCallDateCall grade
PRA ProAssurance Corporation Q1 2024 2024-05-11 D
AES The AES Corporation Q1 2024 2024-05-03 C+
PDS Precision Drilling Corporation Q1 2024 2024-04-25 B
LEGH Legacy Housing Corporation Q4 2023 2024-03-18 C
ALL The Allstate Corporation Q3 2023 2023-11-02 C+
DAL Delta Air Lines, Inc. Q2 2023 2023-07-13 A
UAL United Airlines Holdings, Inc. Q4 2022 2023-01-18 B
STM STMicroelectronics NV Q3 2018 2018-10-24 C+
ESS Essex Property Trust, Inc. Q2 2018 2018-08-03 B+
IRT Independence Realty Trust, Inc. Q2 2018 2018-08-02 B
RACE Ferrari N.V. Q3 2017 2017-11-02 C+
HPP Hudson Pacific Properties, Inc. Q4 2015 2016-02-25 C

How the model reasoned

LEGH · Q4 2023 → YESThe question is: Does management convey that WHAT THE COMPANY SELLS IS BECOMING HARDER FOR BUYERS TO OBTAIN — availability tightening — AND that management is allowing that tightening to work in the c...YES The transcript shows management explicitly holding production levels steady to build backlog rather than ramping output, while continuing to hold pricing levels. Duncan Bates states: “We have held pricing levels and held production levels as we continue to build a backlog across the manufacturing plants” and later “we decided, hey, let's keep production where it is and keep building the backlog.
STM · Q3 2018 → YESThe question is: Does management convey that WHAT THE COMPANY SELLS IS BECOMING HARDER FOR BUYERS TO OBTAIN — availability tightening — AND that management is allowing that tightening to work in the c...YES The transcript shows management describing current shortages and a "stretched supply chain" for their own products (especially Automotive and Power Discrete), with backlogs confirming demand outrunning availability. They explicitly note pricing upside from the fractured supply situation in Power and treat the tightness as a positive dynamic rather than an urgent problem to fix.
ALL · Q3 2023 → YESThe question is: Does management convey that WHAT THE COMPANY SELLS IS BECOMING HARDER FOR BUYERS TO OBTAIN — availability tightening — AND that management is allowing that tightening to work in the c...YES The transcript shows management explicitly restricting new business growth in unprofitable states (California, New York, New Jersey down 75% in new applications) and describing this as part of the profit improvement plan that is working in their favor by improving margins and allowing selective removal of restrictions only where target returns are achieved.

More from the question bank

Proof-point cadenceSomeone else already paid for the growthCorrecting the record with current factsLocus of control flipAhead of their own clockBetting on one customer's rampAll questions →
Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our methodology.